Vast Majority of Drug Ads in Leading Medical Journals Don’t Pass MDs’ Sniff Test!
A study led by Mount Sinai School of Medicine researchers of 192 pharmaceutical advertisements (83 full unique advertisements) in biomedical journals found that only 18 percent (15) were compliant with Food and Drug Administration (FDA) guidelines, and over half failed to quantify serious risks including death.
Pfizer’s Chapstick Slapstick Facebook Fiasco
If pharma marketers are going to be successful engaging consumers (mostly women) via social media, then they need to be more sensitive about how they portray women in ads and very savvy about how they handle comments (if they allow comments).
Antidepressants: Top Advertised & 3rd Most Commonly Used Rx Drug
According to a recent CDC Data Brief, antidepressants were the third most common prescription drug taken by Americans of all ages in 2005–2008 and the most frequently used by persons aged 18–44 years. From 1988–1994 through 2005–2008, the rate of antidepressant use in the United States among all ages increased nearly 400%. Perhaps not so coincidentally, antidepressants are among the TOP advertised Rx category in 2010, according to the recent AdAge analysis.
Physician Participation in Peer-to-Peer Social Media Sites
This article summaries research data exploring why physicians interested in using online peer-to-peer social communities outnumber by 2 to 1 physicians who are actually using them. Includes suggestions for what these communities must do in order to provide more value to physicians.
Breaking the 140-character Limit of Twitter
Opening the Door to FDA-Compliant Branded Tweets: Deck.ly has enormous potential for pharmaceutical marketers who have been chaffing at the bit to post meaningful branded messages via Twitter but who have been stymied by lack of guidance from FDA regarding how to provide fair balance within the 140-character limit of Twitter.
The Socialisation of the Internet is Bogus
The whole web is now socialised..
FDA to Test New Standard for Easy to Understand Drug Labels
Patients also need more effective counseling about their medications. In an effort to make drug package inserts easier to read and understand -- and perhaps to save money on printing costs -- the FDA is planning to test single-page consumer information sheets that would replace the multi-page package inserts and medication guides widely used in retail pharmacies. However 'dumbed down' the label gets, it is still important that physicians and pharmacists take a more pro-active role in educating consumers about the drugs they are taking.
PR & Interactive Agencies Vie for Pharma Social Media Campaign Crumbs
Should a PR firm or an interactive marketing agency be in charge of pharma social media campaigns?
Adverse Event Reporting: A Missed Opportunity
When asked what the # 1 concern pharmaceutical marketers have regarding using social media, the adverse event reporting (AER) boogey man is cited most often. The urge to avoid this boogey man at all costs may have more to do with CEO compensation that with fears of rank-an-file marketers.
Vast Majority of Drug Ads in Leading Medical Journals Don’t Pass MDs’ Sniff Test!
A study led by Mount Sinai School of Medicine researchers of 192 pharmaceutical advertisements (83 full unique advertisements) in biomedical journals found that only 18 percent (15) were compliant with Food and Drug Administration (FDA) guidelines, and over half failed to quantify serious risks including death.